Clin2
NCT06421818Possibly a fitRecruiting

Baitouweng Decoction for ulcerative colitis with damp-heat

Ulcerative Colitis

Part of Digestive system clinical trials.

This trial tests a traditional Chinese herbal formula called Baitouweng Decoction for people with mild to moderate ulcerative colitis who also have a specific pattern of symptoms called 'damp-heat' in the large intestine. It aims to see if the medicine can help reduce inflammation and improve symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
144 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have been diagnosed with ulcerative colitis (a type of inflammatory bowel disease).
  • Your disease is mild to moderate active (Mayo score between 3 and 8).
  • You have symptoms of 'damp-heat' in the large intestine according to traditional Chinese medicine — like diarrhea with mucus or blood, belly pain, or feeling like you need to go often.
  • You can tolerate the herbal medicine Baitouweng Decoction.
  • You are able to have a colonoscopy and a related procedure (TET) if needed.
  • You are willing to join the study and follow the process.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06615765Not yet recruiting
Acupuncture for symptom relief in ulcerative colitis

This trial tests whether acupuncture can help ease symptoms like abdominal pain and diarrhea in people with mild to moderate ulcerative colitis. If you join, you can keep taking your current UC medications (like mesalamine) while receiving acupuncture.

NCT07184996Recruiting· Phase 3
Study of duvakitug for moderate to severe ulcerative colitis

This study tests a new drug called duvakitug for people with moderate to severe ulcerative colitis that hasn't been helped enough by standard treatments. The goal is to see if this medicine can reduce inflammation and improve symptoms.

Peoria, Arizona
NCT06838845Recruiting
A study on upadacitinib for Chinese adults with moderate to severe ulcerative colitis

This study is looking at how well the drug upadacitinib works and how safe it is for Chinese adults with moderate to severe ulcerative colitis. It is not a treatment trial, but will observe patients who are already taking upadacitinib as decided by their doctor.

Guangzhou, Guangdong
NCT07335055Recruiting· Phase 2
Testing HSK47388 for moderate to severe ulcerative colitis

This study tests an experimental drug called HSK47388 for people with moderate to severe ulcerative colitis who have not had good results from other treatments. The goal is to see if it can reduce inflammation and improve symptoms.

Hangzhou
NCT06754891Recruiting· Phase 1
A study of TQH3906 for moderate to severe inflammatory bowel disease

This trial tests a new medicine (TQH3906) for people with moderate to severe ulcerative colitis or Crohn's disease that hasn't improved with other treatments. The goal is to see if it can help control inflammation in the gut.

Bengbu, Anhui
NCT06667934Not yet recruiting· Phase 1/Phase 2
Zuoqing SAN herbal medicine for ulcerative colitis

This trial tests a Chinese herbal medicine called Zuoqing SAN for treating mild to moderate ulcerative colitis. It aims to see if it can help reduce inflammation and improve symptoms.

Hear when a new Ulcerative Colitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.